Biomarkers in Heart Disease / Edition 1

by James de Lemos

Overview

Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.

The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scenarios rather than individual biomarkers.

This book will help the practicing physician decide which biomarkers to measure, when to measure them, how to interpret the results and how to make decisions based on the test result.

Product Details

ISBN-13:	9781405175715
Publisher:	Wiley
Publication date:	05/12/2008
Series:	American Heart Association Clinical Series , #3
Pages:	256
Product dimensions:	5.90(w) x 9.20(h) x 0.80(d)

About the Author

James de Lemos, MD, Associate Professor of Medicine; J. Fred Schoellkopf, Jr. Chair in Cardiology Research, Director, Coronary Care Unit and Cardiology Fellowship Program, UT Southwestern Medical Center, Dallas, TX, USA.

Table of Contents

Part I Biomarkers for the Evaluation of Patients with Ischemic Heart Disease.

1 Protocols for Diagnosing Myocardial Infarction.

2 Troponin and Other Markers of Necrosis for Risk Stratification in Patients with Acute Coronary Syndromes.

3 Challenges Interpreting Cardiac Troponin Values.

4 Natriuretic Peptides and Inflammatory Markers for Risk Stratification in Patients with Ischemic Heart Disease.

5 Novel Markers in Patients with Suspected ACS.

Part II Biomarkers for Evaluation of Patients with Heart Failure.

6 Use of Natriuretic Peptides in the Diagnosis of Heart Failure.

7 Biomarkers for Risk Stratification in Patients with Heart Failure.

8 Natriuretic Peptides for Disease Monitoring in Patients with Chronic Heart Failure.

Part III Biomarkers for Screening in the Ambulatory Populations.

9 CRP.

10 Newer Markers for Population Screening.

Part IV A Look to the Future.

11 Moving Toward Personalized Medicine.

What People are Saying About This

From the Publisher

“A vital contribution to a high-interest and emerging field, this comprehensive but concise discussion of the role of biomarkers in contemporary cardiovascular medicine focuses both on indications for biomarkers in current use as well as on new biomarkers. It is an essential read for anyone interested in the use of biomarkers in clinical practice. The quality and content of the book is excellent. It is a valuable resource for cardiovascular physicians, midlevel providers, or students in a rapidly changing field of cardiovascular medicine.” Doodys Reviews

Editorial Reviews

Reviewer: Timir K Paul, MD, PhD (East Tennessee State University Quillen College of Medicine)
Description: This multiauthored reference on biomarkers in heart disease is written by international leaders in their respective fields.
Purpose: The book provides a clear outline of the role of biomarkers in contemporary cardiovascular disease. Up-to-date information on biomarkers can help physicians decide which biomarkers to measure, when to measure them, and how to interpret the results.
Audience: The intended audience includes cardiologists, internists with an interest in cardiology, physicians in training, medical students, and midlevel providers.
Features: Based upon clinical scenarios, the book is divided into four parts. Part one focuses on biomarkers in patients with ischemic heart disease; part two addresses heart failure; part three is population screening; and part four addresses future needs. The tables and graphs in each chapter are very helpful for eyeballing and interpreting the study findings. The evidence-based tables, graphs, and numerous illustrations with appropriate references are easy to understand and concepts are fairly detailed. The pathophysiology, structures, and mechanisms of the biomarkers in relation to disease processes help readers to understand the basic concepts in relation to clinical decision making.
Assessment: The quality and content of the book is excellent. It is a valuable resource for cardiovascular physicians, midlevel providers, or students in a rapidly changing field of cardiovascular medicine.

Doody's Review Service

A vital contribution to a high-interest and emerging field, this comprehensive but concise discussion of the role of biomarkers in contemporary cardiovascular medicine focuses both on indications for biomarkers in current use as well as on new biomarkers. It is an essential read for anyone interested in the use of biomarkers in clinical practice. The quality and content of the book is excellent. It is a valuable resource for cardiovascular physicians, midlevel providers, or students in a rapidly changing field of cardiovascular medicine.” Doodys Reviews

From the Publisher